Suppressing clk-1 restores lifespan and mitochondrial function in psd-1 deficient worms
Targeting ubiquinone biosynthesis counteracted reduced oxygen consumption and rescued lifespan loss caused by mitochondrial phosphatidylethanolamine deficiency in Caenorhabditis elegans.
Antioxidants (Basel, Switzerland) · Vadupu L et al. · Paper published 20 Sep 2026
In the nematode worm Caenorhabditis elegans, researchers established a model of mitochondrial membrane lipid deficiency by knocking down psd-1, the ortholog of human PISD. The enzyme converts phosphatidylserine to phosphatidylethanolamine within the inner mitochondrial membrane. Knocking down psd-1 lowered mitochondrial phosphatidylethanolamine levels by 69.51% compared to controls, causing developmental defects, altered oxygen consumption, and a reduced lifespan of 13.48 days.
To test how this dysfunction translates into pathology, the authors performed a co-knockdown of psd-1 and clk-1, an electron transport chain component involved in ubiquinone biosynthesis. Inhibiting clk-1 normalized oxygen consumption rates and restored worm lifespan to 17.36 days. These results suggest that retrograde signaling mediated by the electron transport chain, rather than phospholipid depletion by itself, drives the physiological defects in this model.
Why it matters
Mitochondrial membrane lipid composition and electron transport chain signaling actively shape cellular stress responses and longevity. Identifying retrograde pathways that overcome lipid-driven mitochondrial defects provides insight into how metabolic and mitochondrial stress might be managed during aging.
Caveats
The study was conducted exclusively in C. elegans using gene knockdown techniques. It remains unknown whether these genetic interactions and retrograde signaling mechanisms function identically in mammalian or human tissues.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Modulating Ubiquinone Biosynthesis Rescues Mitochondrial Dysfunction by Genetic Interaction in a Phosphatidylethanolamine (PE)-Deficient Disease Model
Vadupu L, Mavuduru VA, Basu Ball W
Antioxidants (Basel, Switzerland) · 20 Sep 2026 · Peer-reviewed
- Relevance
- Core geroscience
- News value
- Notable
- Evidence
- Model organisms
- Status
- Peer-reviewed
More on Mitochondria
See allCardiolipin loss drives muscle fiber shifts during aging via a nuclear receptor
Restoring cardiolipin synthesis in knockout mice reversed muscle atrophy and prevented premature death.
Nature aging · Finger F et al.
Early-life mitochondrial DNA mutations drive age-related pathology in mice
Manipulating mitochondrial fusion can alter tissue-specific selection against deleterious variants that arise early in development.
bioRxiv · Shemtov SJ et al.
Inhibiting miR-128-3p restores muscle mass and function in aged mice
The microRNA inhibitor also improved cardiac outcomes after infarction and reduced pathology in mouse and pig models of muscular dystrophy.
bioRxiv : the preprint server for biology · Boldridge MA et al.
Prodh2 inhibition alleviates muscle atrophy and restores strength in COPD mice
TNF-alpha triggers a mitochondrial immune pathway via Prodh2 that damages myoblasts, while silencing the enzyme restores muscle strength in mice.
Aging cell · Chen G et al.
Depp1 drives muscle loss under fasting and low oxygen in mice
The study reveals that the protein localizes to mitochondria to regulate autophagy and mitochondrial degradation during nutrient and oxygen limitation.
bioRxiv · Qayyum S et al.